Stay updated on Eptinezumab Efficacy in Refractory Migraine Clinical Trial

Sign up to get notified when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The update reflects a minor ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3) without changing the underlying study record information.
    Difference
    0.1%
    Check dated 2026-04-24T06:16:04.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was deleted.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:07:58.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:16.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision history shows a new entry for Revision v3.4.2 replacing v3.4.1, which is an internal version-tracking update and does not modify study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:19:36.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.1) was added to the history, replacing the previous revision (v3.4.0), and it appears to be a minor administrative update with no changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:23:40.000Z thumbnail image

Stay in the know with updates to Eptinezumab Efficacy in Refractory Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.